|Syngenta AG -- USA Stock|| |
USD 459.75 4.55 1%
Head Research & Development
Ms. Patricia Malarkey is Head Research Development, Member of the Executive Committee at Syngenta Ltd since 2014. Prior to her current role as Head Research Development, Patricia Malarkey was Head Research Development for Lawn Garden at Syngenta . Before that, she held a number of senior scientific positions in Crop Protection, Seeds and Biotechnology at Syngenta in Europe and the United States. She graduated from the University of Glasgow in Agricultural Chemistry and holds a Master degree in Toxicology from the University of Surrey.
Age: 50 Executive Since 2014
41 61 323 1111 http://www.syngenta.com
The company has return on total asset (ROA)
of 5.85 %
which means that it generated profit of $5.85 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 12.45 %
meaning that it generated $12.45 on every $100 dollars invested by stockholders.
The company has accumulated 5.63 B in total debt with debt to equity ratio (D/E) of 63.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Syngenta AG has Current Ratio of 1.6 which is within standard range for the sector.
Syngenta AG, an agribusiness company, engages in the discovery, development, manufacture, and marketing of a range of solutions designed to enhance crop yields and food quality worldwide. Syngenta AG (SYENF) is traded on OTC Market in USA. It is located in Basel, and employs 28,000 people.